Department of Urology, Indiana University School of Medicine, Indianapolis, IN.
Department of Urology, Emory University School of Medicine, Atlanta, GA.
Urology. 2024 Jan;183:147-156. doi: 10.1016/j.urology.2023.07.050. Epub 2023 Oct 16.
To examine the performance of the Palacios et al [Aguilar Palacios D, Wilson B, Ascha M, et al. New baseline renal function after radical or partial nephrectomy: a simple and accurate predictive model. J Urol. 2021;205:1310-1320] post-nephrectomy future glomerular function rate (fGFR) equation in a diverse cohort using both the Chronic Kidney Disease Epidemiology (CKD-EPI) 2009 equation with race, used in the creation of the formula, as well as the CKD-EPI 2021 equation without race.
Patients who underwent partial or radical nephrectomy for renal cell carcinoma from 2005-2021 were identified in our institutional database. Patients with creatinine values preoperatively and 3-12 months postoperatively were included. Correlation/bias/accuracy/precision of the fGFR equation (fGFR = 35+ [preoperative eGFR × 0.65] - 18 [if radical] - [age × 0.25] + 3 [if tumor >7 cm] - 2 [if diabetes]) with observed postoperative eGFR was determined by both the CKD-EPI-2021 and CKD-EPI 2009 equations.
A total of 1443 patients were analyzed. Seventy-one percent (1024) were White and 22.9% (331) were Black. Most underwent radical nephrectomy (60.3%). 40% T3-T4 renal cell carcinoma (RCC), with 14.8% of patients having M1 disease. Median observed vs predicted fGFR was 58.0 vs 58.7 mL/min/1.73 m for CKD-EPI 2021 and 56.0 vs 57.5 for CKD-EPI 2009. For the total cohort, the correlation/bias/accuracy/precision of the fGFR equation was 0.805/-0.5/81.7/7.9-9.0 for CKD-EPI 2021 and 0.809/-0.8/81.3/-8.1 to 8 for CKD-EPI 2009. In Black patients, fGFR equation demonstrated >75% accuracy with both CKD-EPI equations; however, accuracy was lower in black patients with the CKD-EPI2021 equation (76.1% vs 83.4%, P = .003).
The fGFR equation performed well in our large, diverse cohort, though accuracy was relatively lower when using CKD-EPI 2021 compared to CKD-EPI 2009.
使用创建公式时使用的种族的慢性肾脏病流行病学(CKD-EPI)2009 方程以及没有种族的 CKD-EPI 2021 方程,在不同队列中检验 Palacios 等人的术后肾小球滤过率(fGFR)方程的性能[Aguilar Palacios D, Wilson B, Ascha M, 等。根治性或部分肾切除术后新的基础肾功能:一种简单而准确的预测模型。J Urol. 2021;205:1310-1320]。
在我们的机构数据库中确定了 2005-2021 年因肾细胞癌接受部分或根治性肾切除术的患者。纳入术前和术后 3-12 个月有肌酐值的患者。通过 CKD-EPI-2021 和 CKD-EPI 2009 方程确定 fGFR 方程(fGFR=35+[术前 eGFR×0.65]-18[如果是根治性]–[年龄×0.25]+3[如果肿瘤>7cm]-2[如果糖尿病])与观察到的术后 eGFR 的相关性/偏差/准确性/精度。
共分析了 1443 名患者。71%(1024 人)为白人,22.9%(331 人)为黑人。大多数患者接受根治性肾切除术(60.3%)。40% T3-T4 肾细胞癌(RCC),14.8%的患者有 M1 期疾病。中位观察到的与预测的 fGFR 分别为 CKD-EPI 2021 为 58.0 vs 58.7mL/min/1.73m,CKD-EPI 2009 为 56.0 vs 57.5。对于整个队列,fGFR 方程的相关性/偏差/准确性/精度为 CKD-EPI 2021 为 0.805/-0.5/81.7/7.9-9.0,CKD-EPI 2009 为 0.809/-0.8/81.3/-8.1 至 8。在黑人患者中,两种 CKD-EPI 方程的 fGFR 方程的准确性均>75%;然而,在使用 CKD-EPI2021 方程时,黑人患者的准确性较低(76.1%比 83.4%,P=0.003)。
fGFR 方程在我们的大型、多样化队列中表现良好,尽管与 CKD-EPI 2009 相比,使用 CKD-EPI 2021 时准确性相对较低。